Deal Note: Crowell & Moring Client Integrated BioTherapeutics Enters Into Exclusive Agreement with Chembio Diagnostics to Develop POC Diagnostic Tests for Ebola
Firm News | less than 1 min read | 10.27.14
Washington, D.C. – October 27, 2014: Crowell & Moring, LLP is representing Integrated BioTherapeutics, Inc. (IBT), a biotechnology company focused on the discovery of novel vaccines and therapeutics for emerging infectious diseases, as it enters into an exclusive agreement with Chembio Diagnostics, Inc., a leader in point-of-care (POC) diagnostic tests for infectious diseases. Under the terms of the agreement, Chembio will combine its patented DPP technology with IBT's proprietary Ebola reagents to develop POC diagnostic tests for Ebola and febrile illness. Chembio will have exclusive rights to any POC product developed through this agreement. Financial terms of the agreement were not disclosed.
Insights
Firm News | 2 min read | 09.17.25
Agustin Orozco Named to Top 100 Lawyers List by the Daily Journal
Los Angeles – September 17, 2025: The Daily Journal has named Crowell & Moring’s Agustin D. Orozco to its 2025 Top 100 list. The annual list, which has been presented by the publication since 2004, celebrates California’s 100 most influential attorneys.
Firm News | 3 min read | 09.11.25
Asset Based Finance Lawyer Tom Dell’Avvocato Joins Crowell & Moring in London
Firm News | 2 min read | 08.22.25
Firm News | 2 min read | 08.21.25
Latinvex Names Crowell & Moring to List of Latin America's Top Law Firms of 2025